MoonLake Immunotherapeutics (MLTX) Earnings Date & Reports

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

MLTX is expected to report earnings to fall 4.98% to -93 cents per share on August 12

MoonLake Immunotherapeutics MLTX Stock Earnings Reports

Q2'26

Est.

$-0.93

Q1'26

Missed

by $0.09

Q4'25

Beat

by $0.06

Q3'25

Missed

by $0.22

Q2'25

Missed

by $0.15

The last earnings report on May 11 showed earnings per share of -98 cents, missing the estimate of -88 cents. With 189.68K shares outstanding, the current market capitalization sits at 1.34B.

View a ticker or compare two or three

Compare

MLTX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for MLTX